INR:3883. cbfs t20 league live score Amgen's Repatha approved for the treatment of primary hypercholesterolemia and mixed dyslipidemia 『Pharmaceutica ...

The FDA approved olezarsen (Tryngolza) as the first drug for adults with familial chylomicronemia syndrome, a rare genetic ...

The global cardiometabolic drugs market is projected to grow from US$ 50 billion in 2021 to over US$ 70 billion by 2032, with a CAGR of 4% to 5%. Sales are expected to surpass US$ 55 billion by 2022, ...

Lim Soo, a professor of endocrine metabolism at Seoul National University Bundang Hospital (a professor of internal medicine ...

New research suggests that activation of the PPARδ protein, which is linked to inflammation, could treat or prevent diabetic cardiomyopathy, a serious heart condition.

Zodasiran is an antisense rnai oligonucleotide commercialized by Arrowhead Pharmaceuticals, with a leading Phase II program in Familial Hypercholesterolemia (Type II Hyperlipoproteinemia).

Fact checked by Nick Blackmer Eli Lilly’s Zepbound bested Novo Nordisk’s Wegovy in the first head-to-head trial comparing ...

Safe and effective statins remain the cornerstone of therapeutic approach for this indication, including for children with genetic dyslipidaemia, and are one of the most widely prescribed drugs in the ...

AZD-0780 is under development for the treatment of cardiovascular disease, familial hypercholesterolemia and dyslipidemia. It is administered orally ... For a complete picture of AZD-0780’s valuation, ...

High cholesterol is a health concern that often goes unnoticed due to its lack of symptoms, allowing it to silently increase ...

The thing that is especially concerning about antiarrhythmic drugs is their unique toxicity, which often makes them difficult and relatively risky to administer and to take. There are two general ...

A 10-panel drug test is a common way to check for various drugs in a person’s body. It typically involves testing urine for drugs, such as cannabinoids, opioids, and more. Typically, traces of ...